Title
Category
Credits
Event date
Cost
  • Substance Use Disorders in Alabama (SUDA)
  • On-Demand
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This presentation will discuss prevalence, impact and treatment of tobacco use disorder. FDA-Approved medications for smoking cessation will be reviewed, including counseling points and access limitations.
  • Substance Use Disorders in Alabama (SUDA)
  • On-Demand
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This presentation will provide information about prescription stimulant misuse. Current statistics of misuse will be presented. Vulnerable populations and rationale for misuse will be discussed. Signs and symptoms of misuse and abuse will be presented along with how to manage patients presenting with toxic effects of prescription stimulants.
  • Substance Use Disorders in Alabama (SUDA)
  • On-Demand
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
A evaluation of non-traditional, legal, substances that are being misused and abused in the community to achieve legal intoxications.
  • Substance Use Disorders in Alabama (SUDA)
  • On-Demand
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
National and Alabama use patterns & trends will be discussed including data from treatment admissions. Risk factors and DSM criteria along with prevalence and epidemiology will be reviewed. A description of available products and relative potency. We will review heavily utilized alternatives like delta-8 and/or delta-10 along with their legal status. We will review in detail the new AL Medical Cannabis Use from the Alabama Compassion Act in 2021 that will be implemented starting 9/1/22. 
  • Substance Use Disorders in Alabama (SUDA)
  • On-Demand
  • COACH
  • 1.20 ABN
  • 1.00 ABSWE
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
$0.00
This presentation will review National and AL data on OUD and use pattern trends. We will discuss risk factors, behavioral clues, and DSM criteria. Epidemiology and prevalence will be discussed. The changing opioid crisis will be discussed with increased emphasis on illicit synthetic opioid use rather than the prescription opioid use driving the current crisis. We will discuss impact of medical cannabis use on patients prescribed opioids for various conditions. 
  • Opioid Training Institute
  • On-Demand
  • COACH
  • 1.20 ABN
  • 1.00 ACPE Pharmacy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
$0.00
This is a case-based presentation on the practical application of risk mitigation strategies already discussed in Part I. Team-based care and clinic optimization will be discussed followed by the presentation of 3 clinical cases that address multiple issues common to practice and clinical pearls will be shared to reinforce previous learning and assist with clinical implementation.
  • COACH
  • 2.40 ABN
  • 2.00 ACPE Pharmacy
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 BDEA
04/08/2024
$25.00
An interactive, 2-hour training session regarding PDMP Usage. Practical application across healthcare professionals with targeted content around common prescribing errors, account maintenance, understanding of prescriber, and patient reports.
  • COACH
  • 2.40 ABN
  • 2.00 ACPE Pharmacy
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 BDEA
04/09/2024
$25.00
An interactive, 2-hour training session regarding PDMP Usage. Practical application across healthcare professionals with targeted content around common prescribing errors, account maintenance, understanding of prescriber, and patient reports.
  • COACH
  • 2.40 ABN
  • 2.00 ACPE Pharmacy
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 BDEA
07/25/2024
$50.00
An interactive, 2-hour training session regarding PDMP Usage. Practical application across healthcare professionals with targeted content around common prescribing errors, account maintenance, understanding of prescriber, and patient reports.

Pages